# Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease

> **NCT00282360** · PHASE4 · COMPLETED · sponsor: **IRCCS San Raffaele** · enrollment: 30 (—)

## Conditions studied

- Coronary Artery Disease
- Type II Diabetes Mellitus

## Interventions

- **DRUG:** Trimetazidine

## Key facts

- **NCT ID:** NCT00282360
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-02
- **Primary completion:** —
- **Final completion:** 2003-10
- **Target enrollment:** 30 (—)
- **Last updated:** 2006-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00282360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00282360, "Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00282360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*